Candida auris since it discovery in 2009 is becoming a severe threat to human health due to its very quickly spread, its worldwide high resistance to systemic antifungal drugs. In resource-constrained settings where several conditions are met for its emergence and spread, this worrisome fungus could cause large hospital and/or community-based outbreaks. This review aimed to summarize the available data on C. auris in Africa focusing on its epidemiology and antifungal resistance profile. Major databases were searched for articles on the epidemiology and antifungal resistance profile of C. auris in Africa. Out of 2,521 articles identified 22 met the inclusion criteria. In Africa, nearly 89% of African countries have no published data on C. auris. The prevalence of C. auris in Africa was 8.74%. The case fatality rate of C. auris infection in Africa was 39.46%. The main C. auris risk factors reported in Africa were cardiovascular disease, renal failure, diabetes, HIV, recent intake of antimicrobial drugs, ICU admissions, surgery, hemodialysis, parenteral nutrition and indwelling devices. Four phylogenetic clades were reported in Africa, namely clades I, II, III and IV. Candida auris showed a pan-African very high resistance rate to fluconazole, moderate resistance to amphotericin B, and high susceptibility to echinocandins. Finally, C. auris clade-specific mutations were observed within the ERG2, ERG3, ERG9, ERG11, FKS1, TAC1b and MRR1 genes in Africa. This systematic review showed the presence of C. auris in the African continent and a worrying unavailability of data on this resilient fungus in most African countries.
References
[1]
Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K. and Yamaguchi, H. (2009) Candida auris sp. nov., a Novel Ascomycetous Yeast Isolated from the External Ear Canal of an Inpatient in a Japanese Hospital. Microbiology and Immunology, 53, 41-44. https://doi.org/10.1111/j.1348-0421.2008.00083.x
[2]
Lee, W.G., Shin, J.H., Uh, Y., Kang, M.G., Kim, S.H., Park, K.H., et al. (2011) First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris. Journal of Clinical Microbiology, 49, 3139-3142. https://doi.org/10.1128/JCM.00319-11
[3]
Chybowska, A.D., Childers, D.S. and Farrer, R.A. (2020) Nine Things Genomics Can Tell Us about Candida auris. Frontiers in Genetics, 11, Article 526662. https://doi.org/10.3389/fgene.2020.00351
[4]
Rhodes, J. and Fisher, M.C. (2019) Global Epidemiology of Emerging Candida auris. Current Opinion in Microbiology, 52, 84-89. https://doi.org/10.1016/j.mib.2019.05.008
[5]
Sabino, R., Veríssimo, C., Pereira, á.A. and Antunes, F. (2020) Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? Microorganisms, 8, Article 181. https://doi.org/10.3390/microorganisms8020181
[6]
Chatterjee, S., Alampalli, S.V., Nageshan, R.K., Chettiar, S.T., Joshi, S. and Tatu, U.S. (2015) Draft Genome of a Commonly Misdiagnosed Multidrug Resistant Pathogen Candida auris. BMC Genomics, 16, Article No. 686. https://doi.org/10.1186/s12864-015-1863-z
[7]
Bravo Ruiz, G. and Lorenz, A. (2021) What Do We Know about the Biology of the Emerging Fungal Pathogen of Humans Candida auris? Microbiological Research, 242, Article ID: 126621. https://doi.org/10.1016/j.micres.2020.126621
[8]
Eggimann, P., Garbino, J. and Pittetd, D. (2003) Epidemiology of Candida species Infections in Critically Ill Nonimmunosuppressed Patients. The Lancet Infectious Diseases, 3, 685-702. https://doi.org/10.1016/S1473-3099(03)00801-6
[9]
Fasciana, T., Cortegiani, A., Ippolito, M., Giarratano, A., Di Quattro, O., Lipari, D., et al. (2020) Candida auris: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen. Antibiotics, 9, Article 778. https://doi.org/10.3390/antibiotics9110778
[10]
Welsh, R.M., Bentz, M.L., Shams, A., Houston, H., Lyons, A., Rose, L.J., et al. (2017) Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. Journal of Clinical Microbiology, 55, 2996-3005. https://doi.org/10.1128/JCM.00921-17
[11]
Fayemiwo, S. and Makanjuola, O.B. (2017) Candida auris Infection: How prepaRed Is Nigeria for This Emerging Fungal Agent? African Journal of Clinical and Experimental Microbiology, 19, 58. https://doi.org/10.4314/ajcem.v19i1.8
[12]
Chowdhary, A., Sharma, C. and Meis, J.F. (2017) Candida auris: A Rapidly Emerging Cause of Hospital-Acquired Multidrug-Resistant Fungal Infections Globally. PLOS Pathogens, 13, e1006290. https://doi.org/10.1371/journal.ppat.1006290
[13]
Chow, N.A., Munoz, J.F., Gade, L., Berkow, E.L., Li, X., Welsh, R.M., et al. (2020) Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. mBio, 11, e03364-19. https://doi.org/10.1128/mBio.03364-19
[14]
Kean, R. and Ramage, G. (2019) Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere, 4, e00458-19. https://doi.org/10.1128/mSphere.00458-19
[15]
Kean, R., Delaney, C., Sherry, L., Borman, A., Johnson, E.M., Richardson, M.D., et al. (2018) Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance. mSphere, 3, e00334-18. https://doi.org/10.1128/mSphere.00334-18
[16]
CDC: Centers for Disease Control and Prevention (2019) Antibiotic Resistance Threats in the United States. Atlanta. https://doi.org/10.15620/cdc:82532
[17]
European Centre for Disease Prevention and Control (2018) Candida auris in Healthcare Settings—Europe. Stock ECDC.
[18]
Kenters, N., Kiernan, M., Chowdhary, A., Denning, D.W., Pemán, J., Saris, K., et al. (2019) Control of Candida auris in Healthcare Institutions: Outcome of an International Society for Antimicrobial Chemotherapy Expert Meeting. International Journal of Antimicrobial Agents, 54, 400-406. https://doi.org/10.1016/j.ijantimicag.2019.08.013
[19]
Bishop (2016) Guidance for the Laboratory Investigation, Management and infEction Prevention and Control for Cases of Candida auris. https://www.gov.uk/government/publications/candida-auris-laboratory-investigation-management-and-infection-prevention-and-control
[20]
World Health Organization (2022) WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. Geneva. https://www.who.int/publications/i/item/9789240060241
[21]
CDC: Centers for Disease Control and Prevention (2022) Antibiotic/Antimicrobial Resistance (AR/AMR) C. auris: CDC’s Response to a Global Emerging Threat. CDC Works to Contain the Global Emerging Threat. https://www.cdc.gov/drugresistance/solutions-initiative/stories/cdc-response-to-global-threat.html
[22]
Kaur, H. and Chakrabarti, A. (2017) Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries. Journal of Fungi, 3, Article 41. https://doi.org/10.3390/jof3030041
[23]
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P.A., et al. (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration. BMJ, 339, b2700. https://doi.org/10.1136/bmj.b2700
[24]
Ostrowsky, B., Greenko, J., Adams, E., Quinn, M., O’Brien, B., Chaturvedi, V., et al. (2020) Candida auris Isolates Resistant to Three Classes of Antifungal Medications—New York, 2019. Morbidity and Mortality Weekly Report, 69, 6-9. https://doi.org/10.15585/mmwr.mm6901a2
[25]
Lockhart, S.R., Etienne, K.A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N.P., et al. (2017) Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clinical Infectious Diseases, 64, 134-140. https://doi.org/10.1093/cid/ciw691
[26]
Ramdin, T.D., Chibabhai, V., Saggers, R.T., Bandini, R.M. and Ballot, D.E. (2023) Epidemiology, Risk Factors and Outcomes Associated with Candidaemia in Very Low Birth Weight Infants at a Tertiary South African Hospital over a 7-Year Period (2013-2019). Clinical Epidemiology and Global Health, 20, Article ID: 101247. https://doi.org/10.1016/j.cegh.2023.101247
[27]
Chibabhai, V. (2022) Incidence of Candidemia and Prevalence of Azole-Resistant Candidemia at a Tertiary South African Hospital—A Retrospective Laboratory Analysis 2016-2020. Southern African Journal of Infectious Diseases, 37, a326. https://doi.org/10.4102/sajid.v37i1.326
[28]
Govender, N.P., Magobo, R.E., Mpembe, R., Mhlanga, M., Matlapeng, P., Corcoran, C., et al. (2018) Candida auris in South Africa, 2012-2016. Emerging Infectious Diseases, 24, 2036-2040. https://doi.org/10.3201/eid2411.180368
[29]
Hussain, M., Whitelaw, A. and Parker, A. (2022) A Five-Year Retrospective Descriptive Study on the Clinical Characteristics and Outcomes of Candidaemia at a Tertiary Hospital in South Africa. IJID Regions, 3, 79-83. https://doi.org/10.1016/j.ijregi.2022.03.003
[30]
Law, T., Chibabhai, V. and Nana, T. (2020) Analysis and Comparison of Cumulative Antibiograms for the Charlotte Maxeke Johannesburg Academic Hospital Adult Intensive Care and High-Care Units, 2013 and 2017. South African Medical Journal, 110, 55-64. https://doi.org/10.7196/SAMJ.2019.v110i1.13841
[31]
Magobo, R.E., Mhlanga, M., Corcoran, C. and Govender, N.P. (2020) Multilocus Sequence Typing of Azole-Resistant Candida auris Strains, South Africa. South African Journal of Infectious Diseases, 35, a116. https://doi.org/10.4102/sajid.v35i1.116
[32]
Maphanga, T.G., Naicker, S.D., Kwenda, S., Munoz, J.F., Schalkwyk, E., van Wadula, J., et al. (2021) In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa. Antimicrobial Agents and Chemotherapy, 65, e0051721. https://doi.org/10.1128/AAC.00517-21
[33]
Mashau, R.C., Meiring, S.T., Dramowski, A., Magobo, R.E., Quan, V.C., Perovic, O., et al. (2022) Culture-Confirmed Neonatal Bloodstream Infections and Meningitis in South Africa, 2014-19: A Cross-Sectional Study. The Lancet Global Health, 10, e1170-e1178. https://doi.org/10.1016/S2214-109X(22)00246-7
[34]
Naicker, S.D., Maphanga, T.G., Chow, N.A., Allam, M., Kwenda, S., Ismail, A., et al. (2021) Clade Distribution of Candida auris in South Africa Using Whole Genome Sequencing of Clinical and Environmental Isolates. Emerging Microbes & Infections, 10, 1300-1308. https://doi.org/10.1080/22221751.2021.1944323
[35]
Parak, A., Stacey, S.L. and Chibabhai, V. (2022) Clinical and Laboratory Features of Patients with Candida auris Cultures, Compared to Other Candida, at a South African Hospital. The Journal of Infection in Developing Countries, 16, 213-221. https://doi.org/10.3855/jidc.14917
[36]
Shuping, L., Mpembe, R., Mhlanga, M., Naicker, S.D., Maphanga, T.G., Tsotetsi, E., et al. (2021) Epidemiology of Culture-Confirmed Candidemia among Hospitalized Children in South Africa, 2012-2017. The Pediatric Infectious Disease Journal, 40, 730-737. https://doi.org/10.1097/INF.0000000000003151
[37]
Magobo, R.E., Corcoran, C., Seetharam, S. and Govender, N.P. (2014) Candida auris-Associated Candidemia, South Africa. Emerging Infectious Diseases, 20, 1250-1251. https://doi.org/10.3201/eid2007.131765
[38]
Van Schalkwyk, E., Mpembe, R.S., Thomas, J., Shuping, L., Ismail, H., Lowman, W., et al. (2019) Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017. Emerging Infectious Diseases, 25, 1698-1707. https://doi.org/10.3201/eid2509.190040
[39]
Von Knorring, N., Nana, T. and Chibabhai, V. (2019) Cumulative Antimicrobial Susceptibility Data for a Tertiary-Level Paediatric Oncology Unit in Johannesburg, South Africa. South African Journal of Oncology, 3, a65. https://doi.org/10.4102/sajo.v3i0.65
[40]
Withers, A., Cronin, K., Mabaso, M., Brisighelli, G., Gabler, T., Harrison, D., et al. (2021) Neonatal Surgical Outcomes: A Prospective Observational Study at a Tertiary Academic Hospital in Johannesburg, South Africa. Pediatric Surgery International, 37, 1061-1068. https://doi.org/10.1007/s00383-021-04881-7
[41]
Adam, R.D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., et al. (2019) Analysis of Candida auris Fungemia at a Single Facility in Kenya. International Journal of Infectious Diseases, 85, 182-187. https://doi.org/10.1016/j.ijid.2019.06.001
[42]
Solomon, D.A., Nyerere, A.K., Kanyua, A. and Ngugi, C.W. (2021) Prevalence, Species Distribution and Antifungal Susceptibility Profile of Candida Species Isolated from Bloodstream of Critical Care Unit Patients in a Tertiary Care Hospital in Kenya. Open Journal of Medical Microbiology, 11, 32-46. https://doi.org/10.4236/ojmm.2021.111003
[43]
Badri, A.M. and Sherfi, S.A. (2019) First Detection of Emergent Fungal Pathogen Candida auris in Khartoum State, Sudan. American Journal of Biomedical Science & Research, 6, 4-7. https://doi.org/10.34297/AJBSR.2019.06.000982
[44]
Oladele, R., Uwanibe, J.N., Olawoye, I.B., Ettu, A.W.O., Meis, J.F. and Happi, C.T. (2022) Emergence and Genomic Characterization of Multidrug Resistant Candida auris in Nigeria, West Africa. Journal of Fungi, 8, Article 787. https://doi.org/10.3390/jof8080787
[45]
Zerrouki, H., Ibrahim, A., Rebiahi, S.A., Elhabiri, Y., Benhaddouche, D.E., de Groot, T., et al. (2022) Emergence of Candida auris in Intensive Care Units in Algeria. Mycoses, 65, 753-759. https://doi.org/10.1111/myc.13470
[46]
Khairat, S.M., Anany, M.G., Ashmawy, M.M. and Hussein, A.F.A. (2021) Setting a Protocol for Identification and Detecting the Prevalence of Candida auris in Tertiary Egyptian Hospitals Using the CDC Steps. Open Access Macedonian Journal of Medical Sciences, 9, 397-402. https://doi.org/10.3889/oamjms.2021.6095
[47]
Maxwell, S. and Abd-Elmonsef, M. (2022) Investigation of Candida auris in Tanta University Hospitals, Egypt. Egyptian Journal of Medical Microbiology, 31, 83-88. https://doi.org/10.21608/ejmm.2022.211980
[48]
El-Kholy, M., Shawky, S., Fayed, A. and Meis, J. (2019) Candida auris Bloodstream Infection in Egypt. 9th Trends in Medical Mycology Held on 11-14 October 2019, Nice, France. Journal of Fungi, 5, 310-311.
[49]
Garcia-Jeldes, H.F., Mitchell, R., McGeer, A., Rudnick, W., Amaratunga, K., Vallabhaneni, S., et al. (2020) Prevalence of Candida auris in Canadian Acute Care Hospitals among At-Risk Patients, 2018. Antimicrobial Resistance & Infection Control, 9, Article No. 82. https://doi.org/10.1186/s13756-020-00752-3
[50]
Briano, F., Magnasco, L., Sepulcri, C., Dettori, S., Dentone, C., Mikulska, M., et al. (2022) Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors. Infectious Diseases and Therapy, 11, 1149-1160. https://doi.org/10.1007/s40121-022-00625-9
[51]
Garcia-Bustos, V., Salavert, M., Ruiz-Gaitán, A.C., Cabanero-Navalon, M.D., Sigona-Giangreco, I.A. and Pemán, J. (2020) A Clinical Predictive Model of Candidaemia by Candida auris in Previously Colonized Critically Ill Patients. Clinical Microbiology and Infection, 26, 1507-1513. https://doi.org/10.1016/j.cmi.2020.02.001
[52]
Benedict, K., Forsberg, K., Gold, J.A.W., Baggs, J. and Lyman, M. (2023) Candida auris-Associated Hospitalizations, United States, 2017-2022. Emerging Infectious Diseases, 29, 1485-1487. https://doi.org/10.3201/eid2907.230540
[53]
Pfaller, M.A. and Diekema, D.J. (2007) Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem. Clinical Microbiology Reviews, 20, 133-163. https://doi.org/10.1128/CMR.00029-06
[54]
Taori, S.K., Khonyongwa, K., Hayden, I., Athukorala, G.D.A, Letters, A., Fife, A., et al. (2019) Candida auris Outbreak: Mortality, Interventions and Cost of Sustaining Control. Journal of Infection, 79, 601-611. https://doi.org/10.1016/j.jinf.2019.09.007
[55]
Vallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., et al. (2017) Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus—United States, May 2013-August 2016. American Journal of Transplantation, 17, 296-299. https://doi.org/10.1111/ajt.14121
[56]
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., et al. (2018) Candida auris in Healthcare Facilities, New York, USA, 2013-2017. Emerging Infectious Diseases, 24, 1816-1824. https://doi.org/10.3201/eid2410.180649
[57]
Teoh, W.H.L. and Kristensen, M.S. (2015) Management of Patients with Angioedema. Cases in Emergency Airway Management, 25, 28-33. https://doi.org/10.1017/CBO9781139941471.005
[58]
Ahmad, S. and Alfouzan, W. (2021) Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities. Microorganisms, 9, Article 807. https://doi.org/10.3390/microorganisms9040807
[59]
Al-Siyabi, T., Al Busaidi, I., Balkhair, A., Al-Muharrmi, Z., Al-Salti, M. and Al’Adawi, B. (2017) First Report of Candida auris in Oman: Clinical and Microbiological Description of Five Candidemia Cases. Journal of Infection, 75, 373-376. https://doi.org/10.1016/j.jinf.2017.05.016
[60]
Ben-Ami, R., Berman, J., Novikov, A., Bash, E., Shachor-meyouhas, Y., Zakin, S., et al. (2017) Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerging Infectious Disease, 23, 195-203. https://doi.org/10.3201/eid2302.161486
[61]
Calvo, B., Melo, A.S.A., Perozo-Mena, A., Hernandez, M., Francisco, E.C., Hagen, F., et al. (2016) First Report of Candida auris in America: Clinical and Microbiological Aspects of 18 Episodes of Candidemia. Journal of Infection, 73, 369-374. https://doi.org/10.1016/j.jinf.2016.07.008
[62]
Chowdhary, A., Sharma, C., Duggal, S., Agarwal, K., Prakash, A., Singh, P.K., et al. (2013) New Clonal Strain of Candida auris, Delhi, India. Emerging Infectious Disease, 19, 1670-1673. https://doi.org/10.3201/eid1910.130393
[63]
Rudramurthy, S.M., Chakrabarti, A., Paul, R.A., Sood, P., Kaur, H., Capoor, M.R., et al. (2017) Candida auris Candidaemia in Indian ICUs: Analysis of Risk Factors. Journal of Antimicrobial Chemotherapy, 72, 1794-1801. https://doi.org/10.1093/jac/dkx034
[64]
Marková, M., Brodská, H., Malícková, K., Válková, V., Cetkovsky, P., Kolár, M., et al. (2013) Substantially Elevated C-Reactive Protein (CRP), Together with Low Levels of Procalcitonin (PCT), Contributes to Diagnosis Of Fungal Infection in Immunocompromised Patients. Supportive Care in Cancer, 21, 2733-2742. https://doi.org/10.1007/s00520-013-1844-1
[65]
Liu, Y., Zhang, X., Yue, T., Tang, Y., Ke, Z., Li, Y., et al. (2022) Combination of C-Reactive Protein and Procalcitonin in Distinguishing Fungal from Bacterial Infections Early in Immunocompromised Children. Antibiotics, 11, Article 730. https://doi.org/10.3390/antibiotics11060730
[66]
Stoma, I., Karpov, I., Uss, A., Krivenko, S., Iskrov, I., Milanovich, N., et al. (2019) Combination of Sepsis Biomarkers May Indicate an Invasive Fungal Infection in Haematological Patients. Biomarkers, 24, 401-406. https://doi.org/10.1080/1354750X.2019.1600023
[67]
Arendrup, M.C., Prakash, A., Metetiadis, J., Sharma, C. and Chowdhary, A. (2017) Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight and Associated Tentative. Antimicrobial Agents and Chemotherapy, 61, e00485-17. https://doi.org/10.1128/AAC.00485-17
[68]
Tsay, S., Welsh, R.M., Adams, E.H., Chow, N.A., Gade, L., Berkow, E.L., et al. (2017) Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities—United States, June 2016-May 2017. Morbidity and Mortality Weekly Report, 66, 514-515. https://doi.org/10.15585/mmwr.mm6619a7
[69]
Rhodes, J., Abdolrasouli, A., Farrer, R.A., Cuomo, C.A., Aanensen, D.M., Armstrong-James, D., et al. (2018) Genomic Epidemiology of the UK Outbreak of the Emerging Human Fungal Pathogen Candida auris. Emerging Microbes & Infections, 7, 1-12. https://doi.org/10.1038/s41426-018-0045-x
[70]
Driemeyer, C., Falci, D.R., Oladele, R.O., Bongomin, F., Ocansey, B.K., Govender, N.P., et al. (2022) The Current State of Clinical Mycology in Africa: A European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey. The Lancet Microbe, 3, e464-e470. https://doi.org/10.1016/S2666-5247(21)00190-7
[71]
Frías-De-león, M.G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castanón-Olivares, L., et al. (2020) Antifungal Resistance in Candida auris: Molecular Determinants. Antibiotics, 9, Article 568. https://doi.org/10.3390/antibiotics9090568
[72]
Rybak, J.M., Sharma, C., Doorley, L.A., Barker, K.S., Palmer, G.E. and Rogers, P.D. (2021) Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance. Microbiology Spectrum, 9, e0158521. https://doi.org/10.1128/Spectrum.01585-21
[73]
Rybak, J.M., Munoz, J.F., Barker, K.S., Parker, J.E., Esquivel, B.D., Berkow, E.L., et al. (2020) Mutations in TAC1B: A Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris. mBio, 11, e00365-20. https://doi.org/10.1128/mBio.00365-20
[74]
Chaabane, F., Graf, A., Jequier, L. and Coste, A.T. (2019) Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris. Frontiers in Microbiology, 10, Article 499266. https://doi.org/10.3389/fmicb.2019.02788
[75]
Biagi, M.J., Wiederhold, N.P., Gibas, C., Wickes, B.L., Lozano, V., Bleasdale, S.C., et al. (2019) Development of High-Level Echinocandin Resistance in a Patient with Recurrent Candida auris Candidemia Secondary to Chronic Candiduria. Open Forum Infectious Diseases, 6, ofz262. https://doi.org/10.1093/ofid/ofz262
